Omenn's syndrome is a variant of combined immunodeficiency disease (CID). L
ike other CID forms, it causes death unless the patient receives a bone mar
row transplant (BMT). Previous reports have shown that BMTs from unrelated
donors in Omenn's syndrome have very poor results, with a high rate of infe
ctions during transplantation and graft rejection, when compared with trans
plants from related donors or patients with other CTD. This study discusses
the case of a 19-month-old child with Omenn's syndrome, who received an un
related cord blood stem cell transplant (CBT). Donor and recipient had 1 HL
A-Ag mismatched on HLA-B. Symptomatology improved early after CBT: The chil
d achieved leukocytes and platelet engraftment and urns discharged on day 34. His follow-up has been uneventful and at this time, 27 months after CBT
immune functions have been recovered.